We are live on
!
Find out more
TAM
TFG Asset Management Portfolio holdings
AUM
$509M
1-Year Est. Return
24.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.32%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$689M
AUM Growth
+$134M
(+24%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-23.24%
Top 10 Holdings %
Top 10 Hldgs %
84.17%
Holding
48
New
9
Increased
13
Reduced
8
Closed
2
Top Buys
| 1 |
UiPath
PATH
|
+$38.2M |
| 2 |
MBX
MBX Biosciences
MBX
|
+$2.38M |
| 3 |
Alkermes
ALKS
|
+$2.09M |
| 4 |
ABVX
Abivax
ABVX
|
+$1.84M |
| 5 |
Arrowhead Research
ARWR
|
+$1.8M |
Top Sells
| 1 |
Tarsus Pharmaceuticals
TARS
|
+$6.15M |
| 2 |
Relay Therapeutics
RLAY
|
+$1.81M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
+$1.78M |
| 4 |
Annexon
ANNX
|
+$1.73M |
| 5 |
Keros Therapeutics
KROS
|
+$1.26M |
Sector Composition
| 1 | Technology | 40.8% |
| 2 | Healthcare | 11.98% |
| 3 | Energy | 6.01% |
| 4 | Materials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$6.19B
| $227M | 32.93% |
16,950,000
+3,227,756
| +24% | +$38.2M |
|
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $59M | 8.57% |
726,900
-95,100
| -12% | -$7.66M |
|
|
KGEI
3
Kolibri Global Energy
KGEI
$182M
| $39.2M | 5.69% |
7,070,568
+1,711
| +0% | +$9.96K |
|
4
Lyft
LYFT
$6.16B
| $22M | 3.2% |
1,000,000
| – | – |
|
5
Sprinklr
CXM
$1.35B
| $17M | 2.47% |
2,200,000
| – | – |
|
|
AUTL
6
Autolus Therapeutics
AUTL
$402M
| $15.5M | 2.25% |
9,500,000
| – | – |
|
7
Workiva
WK
$3.05B
| $12.9M | 1.88% |
150,000
| – | – |
|
8
Celldex Therapeutics
CLDX
$3.01B
| $7.85M | 1.14% |
303,600
-12,550
| -4% | -$291K |
|
|
9
Tarsus Pharmaceuticals
TARS
$2.51B
| $7.43M | 1.08% |
125,000
-125,000
| -50% | -$6.15M |
|
|
10
Annexon
ANNX
$1.06B
| $6.44M | 0.94% |
2,112,455
-697,545
| -25% | -$1.73M |
|
|
11
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $5.92M | 0.86% |
72,961
+4,301
| +6% | +$347K |
|
12
Axsome Therapeutics
AXSM
$12.2B
| $5.64M | 0.82% |
46,456
+4,925
| +12% | +$555K |
|
13
Pharvaris
PHVS
$2.46B
| $4.86M | 0.71% |
194,612
+6,512
| +3% | +$144K |
|
14
Scholar Rock
SRRK
$6.48B
| $4.39M | 0.64% |
117,882
+14,400
| +14% | +$504K |
|
|
TECX
15
Tectonic Therapeutic
TECX
$613M
| $3.82M | 0.56% |
243,728
+14,896
| +7% | +$307K |
|
16
Amylyx Pharmaceuticals
AMLX
$1.98B
| $3.51M | 0.51% |
258,242
+39,492
| +18% | +$372K |
|
|
MBX
17
MBX Biosciences
MBX
$2.89B
| $3.11M | 0.45% |
+177,840
| New | +$2.38M |
|
18
Immunovant
IMVT
$8.19B
| $3.04M | 0.44% |
188,379
+40,562
| +27% | +$657K |
|
19
Dyne Therapeutics
DYN
$3.97B
| $2.82M | 0.41% |
223,181
+84,806
| +61% | +$967K |
|
|
20
Arrowhead Research
ARWR
$10.1B
| $2.82M | 0.41% |
+81,841
| New | +$1.8M |
|
|
21
Alkermes
ALKS
$8.66B
| $2.69M | 0.39% |
89,612
+73,980
| +473% | +$2.09M |
|
|
ABVX
22
Abivax
ABVX
$11.9B
| $2.55M | 0.37% |
+30,000
| New | +$1.84M |
|
23
Snowflake
SNOW
$94.2B
| $2.26M | 0.33% |
10,000
| – | – |
|
|
24
Acadia Pharmaceuticals
ACAD
$4.44B
| $1.84M | 0.27% |
86,071
-75,325
| -47% | -$1.78M |
|
25
Hudbay
HBM
$9.76B
| $1.78M | 0.26% |
117,500
+10,500
| +10% | +$120K |
|
Similar funds
HNW
MCA
OA
PWMG
MC
WDG
B
OWP